Responses
Clinical/translational cancer immunotherapy
Original research
Combinational therapy of CAR T-cell and HDT/ASCT demonstrates impressive clinical efficacy and improved CAR T-cell behavior in relapsed/refractory large B-cell lymphoma
Compose a Response to This Article
Other responses
No responses have been published for this article.
